Indian Sitagliptin Exporters: Complete Supplier Ranking with Market Share — 309 Manufacturers (2026) — TransData Nexus

Q: Who is the largest sitagliptin supplier from India?

DR.REDDY'S LABORATORIES LTD is the largest sitagliptin exporter from India with a 10.2% market share and export value of $7.7M.

Q: How many sitagliptin suppliers are there in India?

There are 309 active sitagliptin exporters in India, collectively shipping $75.8M worth of sitagliptin across 5,364 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top sitagliptin suppliers from India?

The top 5 sitagliptin suppliers from India — DR.REDDY'S LABORATORIES LTD, SANDOZ PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, FREDUN PHARMACEUTICALS LTD — together control 43.8% of total sitagliptin export value from India.

Suresh Sormare

Sitagliptin

India Pharmaceutical Trade Intelligence

$75.8M309 Suppliers121 CountriesHS 30049099

ExportsIndia → CANADA11.6%India → MEXICO11.1%

ImportsCANADA → India$43.8K NETHERLANDS → India$23.2K

#1 Buyer: YILMAZ TRANSPORT

Sitagliptin Suppliers from India (2026) — 309 Exporters, $75.8M Market | TransData Nexus | TransData Nexus

Who Exports Sitagliptin from India — 309 Suppliers Behind a $75.8M Market

India's sitagliptin export market is supplied by 309 active exporters who collectively shipped $75.8M across 5,364 shipments. DR.REDDY'S LABORATORIES LTD leads with a 10.2% market share, followed by SANDOZ PRIVATE LIMITED and MYLAN LABORATORIES LIMITED. The top 5 suppliers together control 43.8% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Sitagliptin Suppliers & Exporters — 309 manufacturers, $75.8M export market, top destinations and formulations — Sitagliptin supplier data — 309 exporters · $75.8M market · 5,364 shipmentsTransData Nexus · Indian Customs Data

Top Sitagliptin Exporters from India — Ranked by Export Value

DR.REDDY'S LABORATORIES LTD is the leading sitagliptin exporter from India, holding a 10.2% share of the $75.8M market across 5,364 shipments from 309 exporters. The top 5 suppliers — DR.REDDY'S LABORATORIES LTD, SANDOZ PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, FREDUN PHARMACEUTICALS LTD — collectively control 43.8% of total export value, indicating a competitive market. Individual shares are: DR.REDDY'S LABORATORIES LTD (10.2%), SANDOZ PRIVATE LIMITED (10.0%), MYLAN LABORATORIES LIMITED (9.2%), HETERO LABS LIMITED (7.6%), FREDUN PHARMACEUTICALS LTD (6.8%).

Top Sitagliptin Exporters from India

Ranked by export value · 309 active suppliers · Indian Customs (DGFT) data

May 2026

Top Sitagliptin Exporters from India — Ranked by Export Value. 309 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Sitagliptin — Export Intelligence Video

Visual overview of India's sitagliptin supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's sitagliptin pharmaceutical supplier landscape — $75.8M in total trade, 309 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Sitagliptin exporters

Certification and compliance status for top Sitagliptin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Dr. Reddy's Laboratories Ltd.	Approved	Yes	Yes	7	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Aurobindo Pharma Ltd.	Warning Letter (June 2019	Yes	Yes	41	Received FDA warning letter in June 2019; holds WHO-GMP and EU GMP certification
Hetero Labs Limited	Approved	Yes	Yes	10	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Mylan Laboratories Limited	Approved	Yes	Yes	Not specified	FDA-approved; holds WHO-GMP and EU GMP certifications.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	10	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Lupin Limited	Approved	Yes	Yes	15	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Zydus Lifesciences Limited	Approved	Yes	Yes	59	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Glenmark Pharmaceuticals Limited	Approved	Yes	Yes	9	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Cipla Limited	Approved	Yes	Yes	Not specified	FDA-approved; holds WHO-GMP and EU GMP certifications.
Biocon Limited	Approved	Yes	Yes	Not specified	FDA-approved; holds WHO-GMP and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 10 leading Sitagliptin exporters from India. 9 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Sitagliptin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous pharmaceutical companies specializing in the synthesis of APIs, including Sitagliptin. The presence of advanced R&D facilities and a skilled workforce contributes to Hyderabad's prominence in API manufacturing. Companies like Granules India Limited, headquartered in Hyderabad, exemplify the region's capacity in producing high-quality APIs.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to several leading pharmaceutical companies that excel in the development and production of finished dosage forms, including Sitagliptin tablets. Intas Pharmaceuticals, headquartered in Ahmedabad, is a notable example, producing a wide range of generic therapeutic drugs. The cluster's emphasis on formulations ensures a steady supply of high-quality Sitagliptin products for both domestic and international markets.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Sitagliptin exporters from India

February 2025

M&A

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires Mayne Pharma's U.S. generic portfolio

Dr. Reddy's Laboratories entered into a definitive agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolio, which includes approximately 45 commercial products, four pipeline products, and 40 approved non-marketed products. IMPACT: This acquisition is expected to enhance Dr. Reddy's presence in the U.S. generic market, potentially increasing resources for Sitagliptin production and export.

Impact: This acquisition is expected to enhance Dr. Reddy's presence in the U.S. generic market, potentially increasing resources for Sitagliptin production and export.

March 2025

M&A

Dr. Reddy's Laboratories Ltd. — Senores Pharma acquires 14 ANDAs from Dr. Reddy's

Senores Pharmaceuticals signed agreements to acquire 14 Abbreviated New Drug Applications (ANDAs) from Dr. Reddy's Laboratories, comprising 13 approved and one pending application. IMPACT: This divestiture may allow Dr. Reddy's to reallocate resources towards core products like Sitagliptin, potentially enhancing export capabilities.

Impact: This divestiture may allow Dr. Reddy's to reallocate resources towards core products like Sitagliptin, potentially enhancing export capabilities.

Common Questions — Sitagliptin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which sitagliptin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, DR.REDDY'S LABORATORIES LTD leads with 243 recorded shipments worth $7.7M. SANDOZ PRIVATE LIMITED (129 shipments) and MYLAN LABORATORIES LIMITED (233 shipments) are also established high-volume exporters.

Q How many sitagliptin manufacturers are there in India?

India has 309 active sitagliptin exporters with a combined export market of $75.8M across 5,364 shipments to 121 countries. The top 5 suppliers hold 43.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for sitagliptin from India?

Average FOB unit price: $6.29 per unit, ranging from $0.00 to $2133.63. Average shipment value: $14.1K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Sitagliptin

Sitagliptin

Who Exports Sitagliptin from India — 309 Suppliers Behind a $75.8M Market

Top Sitagliptin Exporters from India — Ranked by Export Value

Top Sitagliptin Exporters from India

Related Analysis

Need Details?

Sitagliptin — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires Mayne Pharma's U.S. generic portfolio

Dr. Reddy's Laboratories Ltd. — Senores Pharma acquires 14 ANDAs from Dr. Reddy's

Common Questions — Sitagliptin Suppliers from India

Q Which sitagliptin supplier from India is the most reliable for bulk orders?

Q How many sitagliptin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for sitagliptin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires MenoLabs® women's health portfolio

Analysis Methodology